The Affiliated Hospital Of Xuzhou Medical University

This study is testing whether adding an injectable cholesterol-lowering drug (evolocumab) to standard stroke treatment can help prevent patients from getting worse in the first week after a stroke. It involves 132 adults who have just had an ischemic stroke caused by clogged arte…

This study is testing if giving a cholesterol-lowering drug called evolocumab within 6 hours after a successful stroke clot removal procedure helps patients recover better. It will involve 60 stroke patients who have had a clot removed. Half will get the drug plus standard care, …

This is an early safety study to see if a new drug called AT1019 is safe when given with targeted radiation and an immunotherapy drug for people with advanced solid tumors. The main goal is to find the highest dose of AT1019 that patients can tolerate without severe side effects.…

This study is testing an investigational treatment called HN2302 in a small group of adults with myasthenia gravis that hasn't responded well to standard therapies. The main goal is to see if HN2302 is safe and tolerable, while also checking for early signs that it might help imp…

This study is testing a new combination of immunotherapy, chemotherapy, and other drugs for people newly diagnosed with a rare and aggressive type of lymphoma called AITL. The goal is to see if this combination is more effective and safer than current treatments, which often don'…

This study aims to understand why certain diabetes medications work better for some people than others. Researchers will look back at the medical records of 300 people with type 2 diabetes who took specific injectable medications for at least 6 months. They will check if differen…